NCT07472868 2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3 Not yet recruiting
Clinical Trials
84 trialsNCT01042379 2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT05926024 2026-03-11
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
UNC Lineberger Comprehensive Cancer Center
Active not recruiting
NCT06647680 2026-03-06
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
The Affiliated Hospital of Qingdao University
Phase 2 Recruiting
NCT03832569 2026-03-05
Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT06130995 2026-03-05
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
University of Oklahoma
Phase 1 Recruiting
NCT04055220 2026-02-17
REGOSTA
Centre Leon Berard
Phase NA Recruiting
NCT07397442 2026-02-11
Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer
Beijing Friendship Hospital
Phase 2 Not yet recruiting
NCT07353723 2026-01-20
Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
Tang-Du Hospital
Phase 2 Recruiting
NCT07353840 2026-01-20
T-START-CR
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting
NCT07328841 2026-01-09
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Sun Yat-sen University
Phase 3 Recruiting
NCT07328854 2026-01-09
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Recruiting
NCT06364371 2025-12-18
Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Recruiting
NCT01794572 2025-12-12
TOMMY
Institut Cancerologie de l'Ouest
Phase NA Terminated
NCT07007052 2025-11-26
TAGVEN
French Innovative Leukemia Organisation
Phase 2 Not yet recruiting
NCT07066189 2025-10-29
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
Yale University
Phase NA Recruiting
NCT04335669 2025-09-12
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
Lund University Hospital
Phase 3 Active not recruiting
NCT07164872 2025-09-10
Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Not yet recruiting
NCT07166185 2025-09-10
NEOTRAPSCAL
Blida 1 University
Recruiting
NCT06087718 2025-08-14
Feasibility of the Maastro Applicator in Rectal Cancer
Maastricht Radiation Oncology
Phase NA Active not recruiting
NCT06728982 2025-08-01
Impact Of Metformin In Rectal Cancer Patients
Minia University
Phase 2/3 Completed
NCT06811844 2025-07-01
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
The First Affiliated Hospital of Xiamen University
Phase 2 Recruiting
NCT06111807 2025-03-30
MRD-LUNG
University Medical Center Groningen
Recruiting
NCT05416164 2025-03-26
DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
The Netherlands Cancer Institute
Phase NA Recruiting
NCT05976815 2025-03-26
KEYMOVE
University Institute of Maia
Phase NA Recruiting
NCT06889402 2025-03-21
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT04314219 2025-03-13
PTCy-PMAT
King Faisal Specialist Hospital & Research Center
Phase 3 Recruiting
NCT06854107 2025-03-06
Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma
Hubei Cancer Hospital
Completed
NCT06794099 2025-01-27
Study on the Applicability of CCR Criteria in Rectal Cancer
Peking University Cancer Hospital & Institute
Completed
NCT06755567 2025-01-01
Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not yet recruiting
NCT05350722 2024-12-30
ABLATIVE-2
Amsterdam UMC, location VUmc
Phase NA Recruiting
NCT06743555 2024-12-20
SAVED LUNG
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 1 Not yet recruiting
NCT05000697 2024-11-27
CCHOWW
Hospital Alemão Oswaldo Cruz
Phase NA Recruiting
NCT04435197 2024-07-03
PALACE-2
Ruijin Hospital
Phase 2 Completed
NCT01340430 2024-05-09
Neoadjuvant 5-fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Weekly Paclitaxel and Trastuzumab in Her2 Positive Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Phase 2 Completed
NCT05659056 2024-04-16
Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT01686334 2024-03-12
WIDEA
University Hospital, Antwerp
Phase 2 Active not recruiting
NCT06182657 2024-02-08
The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC
Jiangxi Provincial Cancer Hospital
Recruiting
NCT05103293 2023-12-27
PTC Guiding Neoadjuvant Treatment in Breast Cancer
Zhejiang Cancer Hospital
Phase 2 Completed
NCT06180863 2023-12-26
Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients
Yale University
Phase 2 Withdrawn
NCT03125343 2023-11-07
WoW
Sahlgrenska University Hospital
Phase NA Recruiting
NCT05684874 2023-10-30
SarQuantIRM
Centre Leon Berard
Phase NA Unknown
NCT05371860 2023-09-22
Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response
Cedars-Sinai Medical Center
Phase 2 Withdrawn
NCT05925751 2023-06-29
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Unknown
NCT05763992 2023-05-18
BREAKFAST-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Recruiting
NCT05750693 2023-03-02
PIK3CA in HER2+ BC and pCR Trial
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Unknown
NCT04743102 2023-02-21
BIOPSY
Beijing Chao Yang Hospital
Phase NA Recruiting
NCT02233374 2022-10-28
PRISM
Royal North Shore Hospital
Phase NA Completed
NCT04278274 2022-10-26
MR-AI-pCR
Sixth Affiliated Hospital, Sun Yat-sen University
Unknown
NCT05534841 2022-09-10
Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Centre Hospitalier Universitaire de NÄ«mes
Completed